Author:
Kramer Daniel B.,Parasidis Efthimios
Abstract
Many high-risk medical devices earn US marketing approval based on limited premarket clinical evaluation that leaves important questions unanswered. Rigorous postmarket surveillance includes registries that actively collect and maintain information defined by individual patient exposures to particular devices. Several prominent registries for cardiovascular devices require enrolment as a condition of reimbursement for the implant procedure, without informed consent. In this article, we focus on whether these registries, separate from their legal requirements, have an ethical obligation to obtain informed consent from enrolees, what is lost in not doing so, and the ways in which seeking and obtaining consent might strengthen postmarket surveillance in the USA.
Subject
Health Policy,Arts and Humanities (miscellaneous),Issues, ethics and legal aspects,Health (social science)
Reference33 articles.
1. Landscape of cardiovascular device registries in the United States;Rajan;J Am Heart Assoc,2019
2. Bridging unmet medical device ecosystem needs with strategically coordinated registries networks;Krucoff;JAMA,2015
3. The Pew Charitable Trusts . Medical device registries: recommendations for advancing safety and public health 2014.
4. Medical device postapproval safety monitoring: where does the United States stand?;Rajan;Circ Cardiovasc Qual Outcomes,2015
5. US Food and Drug Administration . The least Burdensome provisions of the FDA modernization act of 1997: concept and principles; final guidance for FDA and industry. Available: http://www.fda.gov/medicaldevices/deviceregulationandguidance/guidancedocuments/ucm085994.htm [Accessed 28 Dec 2015].
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献